id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT01928576
|
1:4:chronic_disease
|
HIV-positive patients are excluded
| 1
|
[
"HIV-positive",
"patients",
"are",
"excluded"
] |
[
2,
0,
0,
0
] |
NCT02341209
|
,,,152:163:treatment
|
Women of childbearing potential (WOCBP) must have a negative pregnancy test within 7 days of receiving study medication and monthly while on receiving doxycycline
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"(",
"WOCBP",
")",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"within",
"7",
"days",
"of",
"receiving",
"study",
"medication",
"and",
"monthly",
"while",
"on",
"receiving",
"doxycycline"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02130687
|
16:30:treatment
|
Treatment with anticoagulants
| 1
|
[
"Treatment",
"with",
"anticoagulants"
] |
[
0,
0,
1
] |
NCT02016781
|
15:26:chronic_disease,
|
Patients with de novo MDS who have, or have previously had, Intermediate-2 or High risk disease as determined by the International Prognostic Scoring System (IPSS)
| 1
|
[
"Patients",
"with",
"de",
"novo",
"MDS",
"who",
"have",
",",
"or",
"have",
"previously",
"had",
",",
"Intermediate-2",
"or",
"High",
"risk",
"disease",
"as",
"determined",
"by",
"the",
"International",
"Prognostic",
"Scoring",
"System",
"(",
"IPSS",
")"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01438073
|
4:20:chronic_disease
|
no chronic diseases
| 1
|
[
"no",
"chronic",
"diseases"
] |
[
0,
2,
2
] |
NCT02122185
|
14:38:cancer,40:54:cancer,56:73:chronic_disease
|
evidenced by abdominal carcinomatosis, omental caking, pleural effusions
| 1
|
[
"evidenced",
"by",
"abdominal",
"carcinomatosis",
",",
"omental",
"caking",
",",
"pleural",
"effusions"
] |
[
0,
0,
3,
3,
0,
3,
3,
0,
2,
2
] |
NCT02254863
|
14:23:chronic_disease,25:30:chronic_disease,35:51:chronic_disease,67:89:treatment
|
Uncontrolled bacterial, viral, or fungal infection at the time of pre-UCBT cytoreduction
| 1
|
[
"Uncontrolled",
"bacterial",
",",
"viral",
",",
"or",
"fungal",
"infection",
"at",
"the",
"time",
"of",
"pre-UCBT",
"cytoreduction"
] |
[
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
1,
1
] |
NCT02758847
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT03181516
|
1:21:chronic_disease
|
Congenital anomalies
| 1
|
[
"Congenital",
"anomalies"
] |
[
2,
2
] |
NCT03175159
|
26:29:chronic_disease
|
Involvement in any other HIV Prevention study that may interfere with the ability to test major study outcomes
| 1
|
[
"Involvement",
"in",
"any",
"other",
"HIV",
"Prevention",
"study",
"that",
"may",
"interfere",
"with",
"the",
"ability",
"to",
"test",
"major",
"study",
"outcomes"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03154151
|
29:44:chronic_disease,46:67:chronic_disease,120:131:chronic_disease
|
have a current uncontrolled medical illness, neurological disorder affecting the central nervous system, or history of head injury
| 1
|
[
"have",
"a",
"current",
"uncontrolled",
"medical",
"illness",
",",
"neurological",
"disorder",
"affecting",
"the",
"central",
"nervous",
"system",
",",
"or",
"history",
"of",
"head",
"injury"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02366819
|
1:9:chronic_disease,
|
Diarrhea, grade 1 or greater by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE, version [v] 4.0)
| 1
|
[
"Diarrhea",
",",
"grade",
"1",
"or",
"greater",
"by",
"the",
"National",
"Cancer",
"Institute",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"Events",
"(",
"NCI-CTCAE",
",",
"version",
"[",
"v",
"]",
"4.0",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02192359
|
42:55:treatment
|
Any clinically significant toxicity from prior therapy must have improved to grade 0 or grade 1
| 1
|
[
"Any",
"clinically",
"significant",
"toxicity",
"from",
"prior",
"therapy",
"must",
"have",
"improved",
"to",
"grade",
"0",
"or",
"grade",
"1"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02369653
|
,78:87:treatment
|
Subjects scheduled to have > 3 Lumbar Punctures over the course of the study treatment period
| 1
|
[
"Subjects",
"scheduled",
"to",
"have",
">",
"3",
"Lumbar",
"Punctures",
"over",
"the",
"course",
"of",
"the",
"study",
"treatment",
"period"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02553265
|
24:26:chronic_disease
|
Confirmed diagnosis of FD (genetic testing)
| 1
|
[
"Confirmed",
"diagnosis",
"of",
"FD",
"(",
"genetic",
"testing",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02314221
|
1:16:chronic_disease,18:42:chronic_disease,58:79:chronic_disease
|
Atherosclerosis, congestive heart failure, or history of myocardial infarction
| 1
|
[
"Atherosclerosis",
",",
"congestive",
"heart",
"failure",
",",
"or",
"history",
"of",
"myocardial",
"infarction"
] |
[
2,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2
] |
NCT03145181
|
1:29:treatment,
|
Proteasome inhibitor therapy within 14 days
| 1
|
[
"Proteasome",
"inhibitor",
"therapy",
"within",
"14",
"days"
] |
[
1,
1,
1,
0,
0,
0
] |
NCT02072148
|
1:28:chronic_disease
|
Active peptic ulcer disease defined as unhealed or clinically active
| 1
|
[
"Active",
"peptic",
"ulcer",
"disease",
"defined",
"as",
"unhealed",
"or",
"clinically",
"active"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02099591
|
17:31:chronic_disease
|
newly diagnosed constatipation
| 1
|
[
"newly",
"diagnosed",
"constatipation"
] |
[
0,
0,
2
] |
NCT00632853
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02167022
|
1:41:treatment
|
Anticipated pharmacological intervention or procedure or participation in other studies that may interfere with this study
| 1
|
[
"Anticipated",
"pharmacological",
"intervention",
"or",
"procedure",
"or",
"participation",
"in",
"other",
"studies",
"that",
"may",
"interfere",
"with",
"this",
"study"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03033888
|
17:29:treatment
|
Had undergone a hysterectomy
| 1
|
[
"Had",
"undergone",
"a",
"hysterectomy"
] |
[
0,
0,
0,
1
] |
NCT02501096
|
16:38:treatment,,57:74:treatment,91:103:treatment
|
Has received a live-virus vaccination within 30 days of planned treatment start. Seasonal flu vaccines that do not contain live virus are permitted
| 1
|
[
"Has",
"received",
"a",
"live-virus",
"vaccination",
"within",
"30",
"days",
"of",
"planned",
"treatment",
"start",
".",
"Seasonal",
"flu",
"vaccines",
"that",
"do",
"not",
"contain",
"live",
"virus",
"are",
"permitted"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02833805
|
7:19:cancer,37:52:cancer,64:90:cancer,92:98:cancer,,162:169:cancer
|
Prior malignancies except: resected basal carcinoma or treated cervical carcinoma in situ; cancer treated with curative intent > 5 years previously. Other prior cancers will not be allowed unless approved by the PI
| 1
|
[
"Prior",
"malignancies",
"except",
":",
"resected",
"basal",
"carcinoma",
"or",
"treated",
"cervical",
"carcinoma",
"in",
"situ",
";",
"cancer",
"treated",
"with",
"curative",
"intent",
">",
"5",
"years",
"previously",
".",
"Other",
"prior",
"cancers",
"will",
"not",
"be",
"allowed",
"unless",
"approved",
"by",
"the",
"PI"
] |
[
0,
3,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03019510
|
,,,,,,154:178:chronic_disease,,,,,,
|
body mass index (BMI): 30-45 kg/m2 for the obese subjects <24.5 kg/m2 for the non-obese subjects weight stable during prior 6 months non-smokers OB with impaired fasting glucose: elevated elevated morning fasting glucose levels >110 mg/dL for 5 of 7 days non-obese and OB subjects: fasting glucose levels < 100 mg/dL - 2hr OGTT glucose value <140 mg/dL
| 1
|
[
"body",
"mass",
"index",
"(",
"BMI",
")",
":",
"30-45",
"kg/m2",
"for",
"the",
"obese",
"subjects",
"<",
"24.5",
"kg/m2",
"for",
"the",
"non-obese",
"subjects",
"weight",
"stable",
"during",
"prior",
"6",
"months",
"non-smokers",
"OB",
"with",
"impaired",
"fasting",
"glucose",
":",
"elevated",
"elevated",
"morning",
"fasting",
"glucose",
"levels",
">",
"110",
"mg/dL",
"for",
"5",
"of",
"7",
"days",
"non-obese",
"and",
"OB",
"subjects",
":",
"fasting",
"glucose",
"levels",
"<",
"100",
"mg/dL",
"-",
"2hr",
"OGTT",
"glucose",
"value",
"<",
"140",
"mg/dL"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01433965
|
32:47:chronic_disease,57:80:chronic_disease,84:107:chronic_disease
|
Known sero-positive for active viral infection with HI, hepatitis B virus (HBV) or hepatitis C virus (HCV)
| 1
|
[
"Known",
"sero-positive",
"for",
"active",
"viral",
"infection",
"with",
"HI",
",",
"hepatitis",
"B",
"virus",
"(",
"HBV",
")",
"or",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02679560
|
29:45:treatment,
|
Administration of any other local anesthetic in the 2 hours prior to the study enrollment
| 1
|
[
"Administration",
"of",
"any",
"other",
"local",
"anesthetic",
"in",
"the",
"2",
"hours",
"prior",
"to",
"the",
"study",
"enrollment"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02416206
|
,43:55:treatment
|
Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression
| 1
|
[
"Within",
"9",
"months",
"of",
"the",
"start",
"of",
"induction",
"chemotherapy",
"and",
"no",
"evidence",
"of",
"relapse",
"or",
"progression"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02489045
|
28:48:chronic_disease,52:56:allergy_name,60:72:allergy_name,247:272:chronic_disease
|
Patients with a history of anaphylactic allergy to eggs or egg products, manifested by one or more of the following symptoms: generalized urticaria, difficulty in breathing, swelling of the mouth and throat, hypotension, or shock. (Subjects with nonanaphylactic allergies to eggs or egg products may be enrolled in the study, but must be watched carefully for 1 h following the administration of SONAZOID)
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"anaphylactic",
"allergy",
"to",
"eggs",
"or",
"egg",
"products",
",",
"manifested",
"by",
"one",
"or",
"more",
"of",
"the",
"following",
"symptoms",
":",
"generalized",
"urticaria",
",",
"difficulty",
"in",
"breathing",
",",
"swelling",
"of",
"the",
"mouth",
"and",
"throat",
",",
"hypotension",
",",
"or",
"shock",
".",
"(",
"Subjects",
"with",
"nonanaphylactic",
"allergies",
"to",
"eggs",
"or",
"egg",
"products",
"may",
"be",
"enrolled",
"in",
"the",
"study",
",",
"but",
"must",
"be",
"watched",
"carefully",
"for",
"1",
"h",
"following",
"the",
"administration",
"of",
"SONAZOID",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
4,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563678
|
30:48:treatment
|
medically cleared to work as hyperbaric chamber inside attendants, reporting for a regular duty day
| 1
|
[
"medically",
"cleared",
"to",
"work",
"as",
"hyperbaric",
"chamber",
"inside",
"attendants",
",",
"reporting",
"for",
"a",
"regular",
"duty",
"day"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01243931
|
1:10:chronic_disease,12:27:chronic_disease,29:37:chronic_disease,103:110:treatment
|
Cataracts, retinal disease, glaucoma, or other eye conditions that may limit the visual outcome after surgery
| 1
|
[
"Cataracts",
",",
"retinal",
"disease",
",",
"glaucoma",
",",
"or",
"other",
"eye",
"conditions",
"that",
"may",
"limit",
"the",
"visual",
"outcome",
"after",
"surgery"
] |
[
2,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02811679
|
26:36:cancer,49:73:cancer,75:108:cancer,123:138:cancer,
|
Prior history of another malignancy (except for non-melanoma skin cancer, in situ cervical or breast cancer, or localized prostate cancer) unless disease free for at least one year and felt at low risk of relapse by treating physician
| 1
|
[
"Prior",
"history",
"of",
"another",
"malignancy",
"(",
"except",
"for",
"non-melanoma",
"skin",
"cancer",
",",
"in",
"situ",
"cervical",
"or",
"breast",
"cancer",
",",
"or",
"localized",
"prostate",
"cancer",
")",
"unless",
"disease",
"free",
"for",
"at",
"least",
"one",
"year",
"and",
"felt",
"at",
"low",
"risk",
"of",
"relapse",
"by",
"treating",
"physician"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03027388
|
,,67:82:treatment
|
Pregnant women are excluded from this study because the safety of PP2A inhibition on a developing fetus has not been established
| 1
|
[
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"the",
"safety",
"of",
"PP2A",
"inhibition",
"on",
"a",
"developing",
"fetus",
"has",
"not",
"been",
"established"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02153229
|
,62:74:treatment
|
Subjects who have received more than 2 doses of neo-adjuvant chemotherapy
| 1
|
[
"Subjects",
"who",
"have",
"received",
"more",
"than",
"2",
"doses",
"of",
"neo-adjuvant",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02910700
|
26:56:cancer,60:82:cancer,107:134:treatment
|
Histologically confirmed metastatic melanoma (stage IV) or unresectable stage III that have progressed on prior PD-1 directed therapy
| 1
|
[
"Histologically",
"confirmed",
"metastatic",
"melanoma",
"(",
"stage",
"IV",
")",
"or",
"unresectable",
"stage",
"III",
"that",
"have",
"progressed",
"on",
"prior",
"PD-1",
"directed",
"therapy"
] |
[
0,
0,
3,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT03153410
|
45:75:cancer
|
Have histologically or cytologically proven adenocarcinoma of the pancreas
| 1
|
[
"Have",
"histologically",
"or",
"cytologically",
"proven",
"adenocarcinoma",
"of",
"the",
"pancreas"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02125786
|
32:49:treatment,
|
Interval from start of initial radiation therapy to enrollment > 9 months
| 1
|
[
"Interval",
"from",
"start",
"of",
"initial",
"radiation",
"therapy",
"to",
"enrollment",
">",
"9",
"months"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02195232
|
59:74:treatment
|
central line associated events whereby patients completed anticoagulation
| 1
|
[
"central",
"line",
"associated",
"events",
"whereby",
"patients",
"completed",
"anticoagulation"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01676753
|
28:44:chronic_disease,69:94:treatment,106:141:treatment,153:189:treatment,218:233:treatment,238:244:chronic_disease,246:283:chronic_disease,285:302:chronic_disease,325:341:treatment,,426:441:treatment
|
Patient has a diagnosis of immunodeficiency or is receiving ongoing immunosuppressive therapy, including systemic or enteric corticosteroids except for non-systemically absorbed treatments (such as inhaled or topical steroid therapy for asthma, chronic obstructive pulmonary disease, allergic rhinitis). Patient must be off systemic steroid or any other form of immunosuppressive therapy within 7 days prior to first dose of trial treatment
| 1
|
[
"Patient",
"has",
"a",
"diagnosis",
"of",
"immunodeficiency",
"or",
"is",
"receiving",
"ongoing",
"immunosuppressive",
"therapy",
",",
"including",
"systemic",
"or",
"enteric",
"corticosteroids",
"except",
"for",
"non-systemically",
"absorbed",
"treatments",
"(",
"such",
"as",
"inhaled",
"or",
"topical",
"steroid",
"therapy",
"for",
"asthma",
",",
"chronic",
"obstructive",
"pulmonary",
"disease",
",",
"allergic",
"rhinitis",
")",
".",
"Patient",
"must",
"be",
"off",
"systemic",
"steroid",
"or",
"any",
"other",
"form",
"of",
"immunosuppressive",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"first",
"dose",
"of",
"trial",
"treatment"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03038269
|
8:31:treatment
|
use of anti-seizure medication
| 1
|
[
"use",
"of",
"anti-seizure",
"medication"
] |
[
0,
0,
1,
1
] |
NCT01873131
|
9:26:chronic_disease
|
who are immunocompromised
| 1
|
[
"who",
"are",
"immunocompromised"
] |
[
0,
0,
2
] |
NCT02496663
|
33:39:treatment,82:99:treatment,128:146:treatment
|
Adequate archival tissue from a biopsy performed after progression of disease on previous EGFR-TKI or willing to consent for a fresh tumor biopsy
| 1
|
[
"Adequate",
"archival",
"tissue",
"from",
"a",
"biopsy",
"performed",
"after",
"progression",
"of",
"disease",
"on",
"previous",
"EGFR-TKI",
"or",
"willing",
"to",
"consent",
"for",
"a",
"fresh",
"tumor",
"biopsy"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT00881660
|
1:11:chronic_disease
|
Severe CDH: -Fetal liver herniated into the hemithorax
| 1
|
[
"Severe",
"CDH",
":",
"-Fetal",
"liver",
"herniated",
"into",
"the",
"hemithorax"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01871766
|
,189:201:treatment
|
Participants treated on this protocol in the low or intermediate risk arm who experience disease progression prior to week 13 will transfer to the high risk arm and proceed with high risk chemotherapy starting at week 1 of the protocol
| 1
|
[
"Participants",
"treated",
"on",
"this",
"protocol",
"in",
"the",
"low",
"or",
"intermediate",
"risk",
"arm",
"who",
"experience",
"disease",
"progression",
"prior",
"to",
"week",
"13",
"will",
"transfer",
"to",
"the",
"high",
"risk",
"arm",
"and",
"proceed",
"with",
"high",
"risk",
"chemotherapy",
"starting",
"at",
"week",
"1",
"of",
"the",
"protocol"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02332291
|
22:47:chronic_disease
|
Current diagnosis of major depressive disorder (DSM-IV-TR), single episode, recurrent or chronic, without psychotic features, as detected by MINI and clinical exam
| 1
|
[
"Current",
"diagnosis",
"of",
"major",
"depressive",
"disorder",
"(",
"DSM-IV-TR",
")",
",",
"single",
"episode",
",",
"recurrent",
"or",
"chronic",
",",
"without",
"psychotic",
"features",
",",
"as",
"detected",
"by",
"MINI",
"and",
"clinical",
"exam"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02494869
|
27:40:cancer,
|
Predicted 10-year risk of breast cancer of ≥ 2.31%
| 1
|
[
"Predicted",
"10-year",
"risk",
"of",
"breast",
"cancer",
"of",
"≥",
"2.31",
"%"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02553265
|
43:69:allergy_name
|
Patients with a known hypersensitivity to any component of this drug
| 1
|
[
"Patients",
"with",
"a",
"known",
"hypersensitivity",
"to",
"any",
"component",
"of",
"this",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
4,
4,
4,
4,
4
] |
NCT02264678
|
34:60:cancer
|
advanced recurrent or metastatic non-small cell lung cancer
| 1
|
[
"advanced",
"recurrent",
"or",
"metastatic",
"non-small",
"cell",
"lung",
"cancer"
] |
[
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02577406
|
,,52:73:treatment,77:112:treatment,,165:174:treatment
|
left ventricular ejection fraction (LVEF) < 40% by echocardiogram (ECHO) or multi-gated acquisition (MUGA) scan obtained within 28 days prior to the start of study treatment
| 1
|
[
"left",
"ventricular",
"ejection",
"fraction",
"(",
"LVEF",
")",
"<",
"40",
"%",
"by",
"echocardiogram",
"(",
"ECHO",
")",
"or",
"multi-gated",
"acquisition",
"(",
"MUGA",
")",
"scan",
"obtained",
"within",
"28",
"days",
"prior",
"to",
"the",
"start",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02864147
|
50:76:cancer,
|
All Patients must have a histologic diagnosis of CIN 2,3 cervical lesion(s) confirmed by a study pathologist within past 10 weeks
| 1
|
[
"All",
"Patients",
"must",
"have",
"a",
"histologic",
"diagnosis",
"of",
"CIN",
"2,3",
"cervical",
"lesion",
"(",
"s",
")",
"confirmed",
"by",
"a",
"study",
"pathologist",
"within",
"past",
"10",
"weeks"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02352025
|
21:34:cancer
|
A prior, unrelated, breast cancer
| 1
|
[
"A",
"prior",
",",
"unrelated",
",",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT02439450
|
36:70:treatment
|
Any condition requiring concurrent systemic immunosuppressive therapy
| 1
|
[
"Any",
"condition",
"requiring",
"concurrent",
"systemic",
"immunosuppressive",
"therapy"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT02536794
|
,76:90:treatment
|
A FOCBP is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice)
| 1
|
[
"A",
"FOCBP",
"is",
"any",
"woman",
"(",
"regardless",
"of",
"sexual",
"orientation",
",",
"having",
"undergone",
"a",
"tubal",
"ligation",
",",
"or",
"remaining",
"celibate",
"by",
"choice",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02335242
|
37:40:chronic_disease
|
Has ulcerated or currently infected LMs
| 1
|
[
"Has",
"ulcerated",
"or",
"currently",
"infected",
"LMs"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT02392572
|
14:38:chronic_disease,,,
|
uncontrolled congestive heart failure (New York Heart Association class III and IV)
| 1
|
[
"uncontrolled",
"congestive",
"heart",
"failure",
"(",
"New",
"York",
"Heart",
"Association",
"class",
"III",
"and",
"IV",
")"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02441140
|
27:43:chronic_disease
|
Known or suspected active pelvic infection
| 1
|
[
"Known",
"or",
"suspected",
"active",
"pelvic",
"infection"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02358187
|
1:4:chronic_disease
|
HIV-positive patients
| 1
|
[
"HIV-positive",
"patients"
] |
[
2,
0
] |
NCT03077243
|
,,51:60:treatment
|
CBC/differential obtained within 8 weeks prior to treatment, with adequate bone marrow
| 1
|
[
"CBC/differential",
"obtained",
"within",
"8",
"weeks",
"prior",
"to",
"treatment",
",",
"with",
"adequate",
"bone",
"marrow"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01433315
|
21:31:chronic_disease
|
Those found to have depression on a depression screening tool (BDI-II)
| 1
|
[
"Those",
"found",
"to",
"have",
"depression",
"on",
"a",
"depression",
"screening",
"tool",
"(",
"BDI-II",
")"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181516
|
1:13:treatment
|
Tetracycline
| 1
|
[
"Tetracycline"
] |
[
1
] |
NCT02143726
|
1:58:treatment
|
Chronic concomitant treatment with strong CYP3A4 inducers
| 1
|
[
"Chronic",
"concomitant",
"treatment",
"with",
"strong",
"CYP3A4",
"inducers"
] |
[
1,
1,
1,
1,
1,
1,
1
] |
NCT02390752
|
28:36:cancer
|
Histologic confirmation of PN tumor is not necessary in the presence of consistent clinical and radiographic findings, but should be considered if malignant degeneration of a PN is clinically suspected
| 1
|
[
"Histologic",
"confirmation",
"of",
"PN",
"tumor",
"is",
"not",
"necessary",
"in",
"the",
"presence",
"of",
"consistent",
"clinical",
"and",
"radiographic",
"findings",
",",
"but",
"should",
"be",
"considered",
"if",
"malignant",
"degeneration",
"of",
"a",
"PN",
"is",
"clinically",
"suspected"
] |
[
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02885649
|
1:6:cancer,,
|
Tumor with androgen receptor (AR) expressed >= 4580 copies/ug ribonucleic acid (RNA)
| 1
|
[
"Tumor",
"with",
"androgen",
"receptor",
"(",
"AR",
")",
"expressed",
">",
"=",
"4580",
"copies/ug",
"ribonucleic",
"acid",
"(",
"RNA",
")"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03074240
|
16:33:treatment
|
Chronic use of opioid medication
| 1
|
[
"Chronic",
"use",
"of",
"opioid",
"medication"
] |
[
0,
0,
0,
1,
1
] |
NCT03116997
|
27:63:chronic_disease,,
|
History of severe chronic obstructive pulmonary disease (COPD) defined as an FEV1 < 50% of predicted
| 1
|
[
"History",
"of",
"severe",
"chronic",
"obstructive",
"pulmonary",
"disease",
"(",
"COPD",
")",
"defined",
"as",
"an",
"FEV1",
"<",
"50",
"%",
"of",
"predicted"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01269034
|
1:30:chronic_disease
|
juvenile rheumatoid arthritis
| 1
|
[
"juvenile",
"rheumatoid",
"arthritis"
] |
[
2,
2,
2
] |
NCT03051516
|
40:44:chronic_disease,
|
patients whose screening visit reveals HSIL on biopsy, may be re-screened >= 2 months after therapy
| 1
|
[
"patients",
"whose",
"screening",
"visit",
"reveals",
"HSIL",
"on",
"biopsy",
",",
"may",
"be",
"re-screened",
">",
"=",
"2",
"months",
"after",
"therapy"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02503358
|
,,50:58:chronic_disease
|
Intra-ocular pressure > 21 mmHg, or uncontrolled glaucoma (irrespective of intra-ocular pressure)
| 1
|
[
"Intra-ocular",
"pressure",
">",
"21",
"mmHg",
",",
"or",
"uncontrolled",
"glaucoma",
"(",
"irrespective",
"of",
"intra-ocular",
"pressure",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT01599559
|
200:245:cancer
|
Patients must have histological confirmation of the diagnosis (it is recommended that the immunohistochemical panel includes: CD45, CD20, CD30, CD15, CD10, BCL6, BCL2, MUM-1), and in addition have a dominant mass within the anterior mediastinum
| 1
|
[
"Patients",
"must",
"have",
"histological",
"confirmation",
"of",
"the",
"diagnosis",
"(",
"it",
"is",
"recommended",
"that",
"the",
"immunohistochemical",
"panel",
"includes",
":",
"CD45",
",",
"CD20",
",",
"CD30",
",",
"CD15",
",",
"CD10",
",",
"BCL6",
",",
"BCL2",
",",
"MUM-1",
")",
",",
"and",
"in",
"addition",
"have",
"a",
"dominant",
"mass",
"within",
"the",
"anterior",
"mediastinum"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3
] |
NCT02536794
|
,27:43:cancer
|
#ERROR!
| 1
|
[
"#",
"ERROR",
"!"
] |
[
0,
3,
0
] |
NCT02809677
|
25:42:chronic_disease
|
who have a diagnosis of persistent asthma
| 1
|
[
"who",
"have",
"a",
"diagnosis",
"of",
"persistent",
"asthma"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02099058
|
,,,113:122:treatment
|
Women of childbearing potential must have a negative serum pregnancy test within 14 days prior to initiation of treatment
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"within",
"14",
"days",
"prior",
"to",
"initiation",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02456298
|
1:47:chronic_disease
|
Unstable or degenerative neurological disorder
| 1
|
[
"Unstable",
"or",
"degenerative",
"neurological",
"disorder"
] |
[
2,
2,
2,
2,
2
] |
NCT02515708
|
29:47:chronic_disease
|
Patient with current severe systemic infection
| 1
|
[
"Patient",
"with",
"current",
"severe",
"systemic",
"infection"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02424968
|
,,157:167:cancer
|
diagnosed > 5 years ago without evidence of disease, OR treated =< 5 years ago but have a greater than 50% chance of life expectancy of >= 5 years for that malignancy
| 1
|
[
"diagnosed",
">",
"5",
"years",
"ago",
"without",
"evidence",
"of",
"disease",
",",
"OR",
"treated",
"=",
"<",
"5",
"years",
"ago",
"but",
"have",
"a",
"greater",
"than",
"50",
"%",
"chance",
"of",
"life",
"expectancy",
"of",
">",
"=",
"5",
"years",
"for",
"that",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT03159754
|
1:18:chronic_disease
|
Immunocompromized state
| 1
|
[
"Immunocompromized",
"state"
] |
[
2,
0
] |
NCT01554371
|
51:62:chronic_disease
|
Patients with stable and clinically insignificant CNS disease
| 1
|
[
"Patients",
"with",
"stable",
"and",
"clinically",
"insignificant",
"CNS",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02266719
|
36:45:treatment
|
Patients that are not eligible for treatment with commercially available endografts
| 1
|
[
"Patients",
"that",
"are",
"not",
"eligible",
"for",
"treatment",
"with",
"commercially",
"available",
"endografts"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02857218
|
110:121:treatment
|
because there is an unknown but potential risk for adverse events in nursing infants secondary to the use of ferumoxytol as a contrast agent in the mother
| 1
|
[
"because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"for",
"adverse",
"events",
"in",
"nursing",
"infants",
"secondary",
"to",
"the",
"use",
"of",
"ferumoxytol",
"as",
"a",
"contrast",
"agent",
"in",
"the",
"mother"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02567266
|
63:76:treatment
|
Adolescents will be excluded if they are receiving concurrent psychotherapy
| 1
|
[
"Adolescents",
"will",
"be",
"excluded",
"if",
"they",
"are",
"receiving",
"concurrent",
"psychotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02133196
|
18:21:chronic_disease
|
Seronegative for HIV antibody
| 1
|
[
"Seronegative",
"for",
"HIV",
"antibody"
] |
[
0,
0,
2,
0
] |
NCT01096368
|
54:64:cancer,76:95:chronic_disease,117:122:cancer,313:320:treatment
|
There is no minimum performance level; children with ependymoma may suffer neurologic sequelae as a result of their tumor or surgical measures taken to establish a diagnosis and resect the tumor; in the majority of cases, there is neurologic recovery; neurologic recovery is not likely to be impeded by protocol therapy
| 1
|
[
"There",
"is",
"no",
"minimum",
"performance",
"level",
";",
"children",
"with",
"ependymoma",
"may",
"suffer",
"neurologic",
"sequelae",
"as",
"a",
"result",
"of",
"their",
"tumor",
"or",
"surgical",
"measures",
"taken",
"to",
"establish",
"a",
"diagnosis",
"and",
"resect",
"the",
"tumor",
";",
"in",
"the",
"majority",
"of",
"cases",
",",
"there",
"is",
"neurologic",
"recovery",
";",
"neurologic",
"recovery",
"is",
"not",
"likely",
"to",
"be",
"impeded",
"by",
"protocol",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
2,
2,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02503358
|
34:45:treatment,77:85:treatment,89:93:treatment
|
A history of hypersensitivity to selumetinib, or any excipient agents (e.g. Captisol or TPGS- a water soluble form of Vitamin E)
| 1
|
[
"A",
"history",
"of",
"hypersensitivity",
"to",
"selumetinib",
",",
"or",
"any",
"excipient",
"agents",
"(",
"e.g",
".",
"Captisol",
"or",
"TPGS-",
"a",
"water",
"soluble",
"form",
"of",
"Vitamin",
"E",
")"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01174121
|
40:57:cancer,89:94:cancer,98:120:cancer,122:135:cancer,137:150:cancer,152:158:cancer,160:179:cancer,184:196:cancer
|
Measurable (per RECIST v1.0 criteria), metastatic cancer of one of the following types: upper or lower gastrointestinal, hepatobiliary, genitourinary, breast, ovarian/endometrial, or glioblastoma
| 1
|
[
"Measurable",
"(",
"per",
"RECIST",
"v1.0",
"criteria",
")",
",",
"metastatic",
"cancer",
"of",
"one",
"of",
"the",
"following",
"types",
":",
"upper",
"or",
"lower",
"gastrointestinal",
",",
"hepatobiliary",
",",
"genitourinary",
",",
"breast",
",",
"ovarian/endometrial",
",",
"or",
"glioblastoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
3
] |
NCT01720836
|
,63:72:treatment
|
Subjects must not be more than 12 weeks from standard of care treatment for their particular stage of disease
| 1
|
[
"Subjects",
"must",
"not",
"be",
"more",
"than",
"12",
"weeks",
"from",
"standard",
"of",
"care",
"treatment",
"for",
"their",
"particular",
"stage",
"of",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01836354
|
33:36:chronic_disease
|
Vascular risk factors including HTN history or elevated blood pressure
| 1
|
[
"Vascular",
"risk",
"factors",
"including",
"HTN",
"history",
"or",
"elevated",
"blood",
"pressure"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02394704
|
1:10:chronic_disease
|
psychosis
| 1
|
[
"psychosis"
] |
[
2
] |
NCT01620216
|
105:117:treatment
|
certain agents that prolong the corrected QT interval may be allowed but only after discussion with the chemotherapy pharmacist
| 1
|
[
"certain",
"agents",
"that",
"prolong",
"the",
"corrected",
"QT",
"interval",
"may",
"be",
"allowed",
"but",
"only",
"after",
"discussion",
"with",
"the",
"chemotherapy",
"pharmacist"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02048722
|
15:32:chronic_disease,34:51:chronic_disease,56:69:chronic_disease
|
Presence of a non-healing wound, non-healing ulcer, or bone fracture
| 1
|
[
"Presence",
"of",
"a",
"non-healing",
"wound",
",",
"non-healing",
"ulcer",
",",
"or",
"bone",
"fracture"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2
] |
NCT02365467
|
18:27:treatment,45:53:chronic_disease,73:85:treatment
|
Subject requires treatment of an infrarenal aneurysm at the time of the implantation
| 1
|
[
"Subject",
"requires",
"treatment",
"of",
"an",
"infrarenal",
"aneurysm",
"at",
"the",
"time",
"of",
"the",
"implantation"
] |
[
0,
0,
1,
0,
0,
0,
2,
0,
0,
0,
0,
0,
1
] |
NCT02565498
|
9:21:treatment
|
Planned chemotherapy for (neo)adjuvant treatment
| 1
|
[
"Planned",
"chemotherapy",
"for",
"(",
"neo",
")",
"adjuvant",
"treatment"
] |
[
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01648751
|
7:24:chronic_disease
|
Known liver dysfunction
| 1
|
[
"Known",
"liver",
"dysfunction"
] |
[
0,
2,
2
] |
NCT02509507
|
15:37:treatment,
|
have received live-virus vaccination within 30 days of planned treatment start
| 1
|
[
"have",
"received",
"live-virus",
"vaccination",
"within",
"30",
"days",
"of",
"planned",
"treatment",
"start"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01625234
|
24:46:chronic_disease
|
Clinically significant cardiovascular disease
| 1
|
[
"Clinically",
"significant",
"cardiovascular",
"disease"
] |
[
0,
0,
2,
2
] |
NCT02581982
|
,,,233:243:treatment,
|
Female subjects of childbearing potential should be willing to use 2 methods of birth control or be surgically sterile, or abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication; subjects of childbearing potential are those who have not been surgically sterilized or have not been free from menses for > 1 year
| 1
|
[
"Female",
"subjects",
"of",
"childbearing",
"potential",
"should",
"be",
"willing",
"to",
"use",
"2",
"methods",
"of",
"birth",
"control",
"or",
"be",
"surgically",
"sterile",
",",
"or",
"abstain",
"from",
"heterosexual",
"activity",
"for",
"the",
"course",
"of",
"the",
"study",
"through",
"120",
"days",
"after",
"the",
"last",
"dose",
"of",
"study",
"medication",
";",
"subjects",
"of",
"childbearing",
"potential",
"are",
"those",
"who",
"have",
"not",
"been",
"surgically",
"sterilized",
"or",
"have",
"not",
"been",
"free",
"from",
"menses",
"for",
">",
"1",
"year"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02474199
|
,,55:65:treatment
|
α-fetoprotein (AFP) less than 100 μg/L at the time of transplant
| 1
|
[
"α-fetoprotein",
"(",
"AFP",
")",
"less",
"than",
"100",
"μg/L",
"at",
"the",
"time",
"of",
"transplant"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02758847
|
39:67:chronic_disease,98:123:treatment,128:155:treatment,159:177:chronic_disease
|
Patient population: all patients with CLI (critical limb ischemia) and tissue loss scheduled for endovascular intervention for femoral popliteal occlusive or multilevel disease
| 1
|
[
"Patient",
"population",
":",
"all",
"patients",
"with",
"CLI",
"(",
"critical",
"limb",
"ischemia",
")",
"and",
"tissue",
"loss",
"scheduled",
"for",
"endovascular",
"intervention",
"for",
"femoral",
"popliteal",
"occlusive",
"or",
"multilevel",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
2,
2
] |
NCT02015390
|
1:20:chronic_disease,,
|
Skeletal immaturity (open growth plate and/or age <18 years)
| 1
|
[
"Skeletal",
"immaturity",
"(",
"open",
"growth",
"plate",
"and/or",
"age",
"<",
"18",
"years",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01743950
|
1:18:cancer
|
Recurrent disease based on combination of clinical, imaging or histologic confirmation
| 1
|
[
"Recurrent",
"disease",
"based",
"on",
"combination",
"of",
"clinical",
",",
"imaging",
"or",
"histologic",
"confirmation"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01988246
|
43:49:allergy_name,53:61:allergy_name,92:102:treatment
|
Patients with a known hypersensitivity to NSAIDs or steroids or any component of the study medication
| 1
|
[
"Patients",
"with",
"a",
"known",
"hypersensitivity",
"to",
"NSAIDs",
"or",
"steroids",
"or",
"any",
"component",
"of",
"the",
"study",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
0,
0,
0,
0,
0,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.